HIV-1 RNA levels in rectal and seminal compartments after switching to long-acting cabotegravir plus rilpivirine: a longitudinal study.

Mar MasiáMarta Fernández-GonzálezVanesa AgullóPaula MascarellSergio PadillaJavier García-AbellánFélix Gutiérrez

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)

HIV-1 RNA levels were longitudinally evaluated in 211 rectal and 152 seminal samples from 12 virologically-suppressed participants switching to monthly long-acting cabotegravir plus rilpivirine or continuing with daily dolutegravir-abacavir-lamivudine. Maintenance of viral suppression in rectal and seminal compartments was comparable and blips occurred with similar frequency with both treatment regimens.

Keyphrases

hiv infected patients
antiretroviral therapy
hiv infected
hiv positive
human immunodeficiency virus
hiv aids
rectal cancer
hiv testing
sars cov
hepatitis c virus
physical activity
men who have sex with men